Article info
PDFBasic and translational research
Extended report
Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis
- Correspondence to Dr Jörg H W Distler, Department of Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Ulmenweg 18, D-91054 Erlangen, Germany; Joerg.distler{at}uk-erlangen.de
Citation
Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis
Publication history
- Received July 4, 2014
- Revised November 4, 2014
- Accepted December 20, 2014
- First published January 14, 2015.
Online issue publication
October 31, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/